Acumen Pharmaceuticals Inc (ABOS)
3.60
-0.21
(-5.51%)
USD |
NASDAQ |
May 22, 16:00
3.61
+0.01
(+0.28%)
After-Hours: 20:00
Acumen Pharmaceuticals Shareholders Equity (Quarterly): 262.03M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 262.03M |
December 31, 2023 | 266.97M |
September 30, 2023 | 280.27M |
June 30, 2023 | 168.87M |
March 31, 2023 | 179.08M |
December 31, 2022 | 188.78M |
September 30, 2022 | 196.65M |
Date | Value |
---|---|
June 30, 2022 | 206.52M |
March 31, 2022 | 216.09M |
December 31, 2021 | 225.18M |
September 30, 2021 | 233.36M |
June 30, 2021 | -106.08M |
March 31, 2021 | -45.46M |
December 31, 2020 | -18.59M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-106.08M
Minimum
Jun 2021
280.27M
Maximum
Sep 2023
160.98M
Average
201.58M
Median
Shareholders Equity (Quarterly) Benchmarks
Accuray Inc | 41.08M |
Kezar Life Sciences Inc | 169.12M |
Akoya Biosciences Inc | 32.72M |
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 300.97M |
Total Liabilities (Quarterly) | 38.93M |